- Home
- FTRE vs CLMT Comparison
FTRE vs CLMT Comparison
Compare FTRE & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- CLMT
- Stock Information
- Founded
- FTRE 1996
- CLMT 1916
- Country
- FTRE United States
- CLMT United States
- Employees
- FTRE N/A
- CLMT N/A
- Industry
- FTRE Medical Specialities
- CLMT Oil & Gas Production
- Sector
- FTRE Health Care
- CLMT Energy
- Exchange
- FTRE Nasdaq
- CLMT Nasdaq
- Market Cap
- FTRE 1.4B
- CLMT 1.4B
- IPO Year
- FTRE N/A
- CLMT 2006
- Fundamental
- Price
- FTRE $14.88
- CLMT $14.93
- Analyst Decision
- FTRE Hold
- CLMT Buy
- Analyst Count
- FTRE 11
- CLMT 5
- Target Price
- FTRE $23.30
- CLMT $23.60
- AVG Volume (30 Days)
- FTRE 1.2M
- CLMT 1.5M
- Earning Date
- FTRE 03-03-2025
- CLMT 02-28-2025
- Dividend Yield
- FTRE N/A
- CLMT N/A
- EPS Growth
- FTRE N/A
- CLMT N/A
- EPS
- FTRE N/A
- CLMT N/A
- Revenue
- FTRE $2,975,600,000.00
- CLMT $4,216,399,999.00
- Revenue This Year
- FTRE N/A
- CLMT N/A
- Revenue Next Year
- FTRE $1.02
- CLMT $1.56
- P/E Ratio
- FTRE N/A
- CLMT N/A
- Revenue Growth
- FTRE 2.80
- CLMT 0.30
- 52 Week Low
- FTRE $14.27
- CLMT $9.97
- 52 Week High
- FTRE $41.02
- CLMT $25.29
- Technical
- Relative Strength Index (RSI)
- FTRE 34.60
- CLMT 35.94
- Support Level
- FTRE $14.88
- CLMT $15.40
- Resistance Level
- FTRE $15.83
- CLMT $19.14
- Average True Range (ATR)
- FTRE 0.69
- CLMT 1.16
- MACD
- FTRE 0.08
- CLMT -0.01
- Stochastic Oscillator
- FTRE 25.85
- CLMT 9.66
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About CLMT Calumet Specialty Products Partners L.P. Common Units
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets.